United States (US) Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report

Published: June 23, 2025 Report Code: GDME25630CCDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “United States Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The United States Oncology Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Oncology Market.
• Global corporate-level profiles of key companies operating within the United States Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Oncology is segmented as follows – _x000D_

• Colorectal Cancer Screening Tests_x000D_

• EGFR Tests_x000D_

• KRAS Tests_x000D_

• HER2 Tests_x000D_

• BRCA Tests_x000D_

• ALK Tests_x000D_

• BRAF Tests_x000D_

• BCR-ABL Tests_x000D_

• PD-L1 Tests

Reasons to Buy

The United States Oncology Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Abbott Laboratories

|1 Table of Contents 3

|1.1 List of Tables 16

|1.2 List of Figures 16

2 Introduction 17

2.1 What Is This Report About? 17

2.2 Oncology Market Segmentation 17

2.3 Definitions of Markets Covered in the Report 19

3 Oncology Market, United States 26

3.1 Oncology Market, United States, Revenue ($m), 2018-2033 26

3.1.1 ALK Tests Market, United States, Revenue ($m), by Segment, 2018-2033 29

3.1.2 BCR-ABL Tests Market, United States, Revenue ($m), by Segment, 2018-2033 31

3.1.3 BRAF Tests Market, United States, Revenue ($m), by Segment, 2018-2033 33

3.1.4 BRCA Tests Market, United States, Revenue ($m), by Segment, 2018-2033 35

3.1.5 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), by Segment, 2018-2033 37

3.1.6 EGFR Tests Market, United States, Revenue ($m), by Segment, 2018-2033 39

3.1.7 HER2 Tests Market, United States, Revenue ($m), by Segment, 2018-2033 41

3.1.8 KRAS Tests Market, United States, Revenue ($m), by Segment, 2018-2033 43

3.2 Oncology Market, United States, Volume (Units), 2018-2033 45

3.2.1 ALK Tests Market, United States, Volume (Units), by Segment, 2018-2033 48

3.2.2 BCR-ABL Tests Market, United States, Volume (Units), by Segment, 2018-2033 50

3.2.3 BRAF Tests Market, United States, Volume (Units), by Segment, 2018-2033 52

3.2.4 BRCA Tests Market, United States, Volume (Units), by Segment, 2018-2033 54

3.2.5 Colorectal Cancer Screening Tests Market, United States, Volume (Units), by Segment, 2018-2033 56

3.2.6 EGFR Tests Market, United States, Volume (Units), by Segment, 2018-2033 58

3.2.7 HER2 Tests Market, United States, Volume (Units), by Segment, 2018-2033 60

3.2.8 KRAS Tests Market, United States, Volume (Units), by Segment, 2018-2033 62

3.3 Oncology Market, United States, Average Price ($) , 2018-2033 64

3.4 Oncology Market, United States, Company Share by Revenue ($m), 2024 67

4 Overview of Key Companies in United States, Oncology Market 69

4.1 Exact Sciences Corp 69

4.1.1 Company Overview 69

4.2 Agilent Technologies Inc 69

4.2.1 Company Overview 69

4.3 F. Hoffmann-La Roche Ltd 69

4.3.1 Company Overview 69

4.4 Abbott Laboratories 69

4.4.1 Company Overview 69

4.5 Qiagen NV 70

4.5.1 Company Overview 70

4.6 Danaher Corp 70

4.6.1 Company Overview 70

4.7 Guardant Health Inc 70

4.7.1 Company Overview 70

4.8 Thermo Fisher Scientific Inc 70

4.8.1 Company Overview 70

4.9 BioGenex Laboratories Inc 71

4.9.1 Company Overview 71

4.10 Bio-Techne Corp 71

4.10.1 Company Overview 71

5 Oncology Market Pipeline Products 72

6 Financial Deals Landscape 137

6.1 Acquisition 137

6.1.1 Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories 137

6.1.2 Hanmi Pharma and LG Invests USD5 Million in MEDiC Life Sciences 139

6.1.3 Starboard Value May Acquire Stake in Pfizer for USD1 Billion 141

6.1.4 VION Biosciences Acquires Ansh Labs 142

6.1.5 DERM-JES Holdings Acquires DermTech 144

6.2 Debt Offerings 145

6.2.1 Breath Diagnostics Raises USD1 Million in Private Placement of Convertible Notes 145

6.2.2 Kiyatec Raises USD0.25 Million in Debt Offering 146

6.2.3 Laboratory Corp of America Holdings Raises USD650 Million in Public Offering of

4.35% Notes Due 2030 147

6.2.4 Laboratory Corp of America Holdings Raised Public Offering of

4.55% Notes Due 2032 for USD500 Million 149

6.2.5 Laboratory Corp of America Holdings Raises USD850 Million in Public Offering of

4.8% Notes Due 2034 151

6.2.6 Illumina Prices USD500 Million in Public Offering of

4.65% Notes Due 2026 153

7 Recent Developments 154

8 Appendix 154

Table

Table 1: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033 28

Table 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 31

Table 3: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 33

Table 4: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 35

Table 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 37

Table 6: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 39

Table 7: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 41

Table 8: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 43

Table 9: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 45

Table 10: Oncology Market, United States, Volume (Units), 2018-2033 47

Table 11: ALK Tests Market, United States, Volume (Units), 2018-2033 50

Table 12: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033 52

Table 13: BRAF Tests Market, United States, Volume (Units), 2018-2033 54

Table 14: BRCA Tests Market, United States, Volume (Units), 2018-2033 56

Table 15: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033 58

Table 16: EGFR Tests Market, United States, Volume (Units), 2018-2033 60

Table 17: HER2 Tests Market, United States, Volume (Units), 2018-2033 62

Table 18: KRAS Tests Market, United States, Volume (Units), 2018-2033 64

Table 19: Oncology Market, United States, Average Price ($), 2018-2033 65

Table 20: Oncology Market, United States, Company Share by Revenue ($m), 2024 69

Table 21: Oncology Market Pipeline Products 73

Table 22: Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories 138

Table 23: Hanmi Pharma and LG Invests USD5 Million in MEDiC Life Sciences 140

Table 24: Starboard Value May Acquire Stake in Pfizer for USD1 Billion 142

Table 25: VION Biosciences Acquires Ansh Labs 143

Table 26: DERM-JES Holdings Acquires DermTech 145

Table 27: Breath Diagnostics Raises USD1 Million in Private Placement of Convertible Notes 146

Table 28: Kiyatec Raises USD0.25 Million in Debt Offering 147

Table 29: Laboratory Corp of America Holdings Raises USD650 Million in Public Offering of 4.35% Notes Due 2030 148

Table 30: Laboratory Corp of America Holdings Raised Public Offering of 4.55% Notes Due 2032 for USD500 Million 150

Table 31: Laboratory Corp of America Holdings Raises USD850 Million in Public Offering of 4.8% Notes Due 2034 152

Table 32: Illumina Prices USD500 Million in Public Offering of 4.65% Notes Due 2026 154

Table 33: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 413

Figures

Figure 1: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033 27

Figure 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 30

Figure 3: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 32

Figure 4: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 34

Figure 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 36

Figure 6: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 38

Figure 7: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 40

Figure 8: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 42

Figure 9: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 44

Figure 10: Oncology Market, United States, Volume (Units), 2018-2033 46

Figure 11: ALK Tests Market, United States, Volume (Units), 2018-2033 49

Figure 12: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033 51

Figure 13: BRAF Tests Market, United States, Volume (Units), 2018-2033 53

Figure 14: BRCA Tests Market, United States, Volume (Units), 2018-2033 55

Figure 15: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033 57

Figure 16: EGFR Tests Market, United States, Volume (Units), 2018-2033 59

Figure 17: HER2 Tests Market, United States, Volume (Units), 2018-2033 61

Figure 18: KRAS Tests Market, United States, Volume (Units), 2018-2033 63

Figure 19: Oncology Market, United States, Company Share (%), 2024 68

United States (US) Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports

Medical Devices

New

Global M&A Deals in H1 2026 - Top Themes by…

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States (US) Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others in real time.

Access a live United States (US) Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

United States (US) Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports